Table 2:
Antibiotic | Odds Ratio of Resistance Polymicrobial v. Monomicrobial | p-value | Odds Ratio of Resistance for Each Additional Species | p-value |
---|---|---|---|---|
Penicillins | ||||
Ampicillin | 1.37 (1.10, 1.70) | 0.005* | 1.14 (1.05, 1.24) | 0.001* |
Combinations | ||||
Amoxicilin/Clavulanate | 1.38 (1.09, 1.74) | 0.008* | 1.16 (1.07, 1.26) | 0.0005* |
Ampicillin/Sulbactam | 1.13 (0.89, 1.42) | 0.32 | 1.05 (0.96, 1.14) | 0.30 |
Trimethoprim/Sulfamethoxazole | 1.09 (0.88, l.37) | 0.43 | 0.98 (0.91, 1.07) | 0.69 |
Piperacillin/TazobactBm | 0.69 (0.43, 1,11} | 0.12 | 0.75 (0.51, 0.94) | 0.010* |
Cephalosporins | ||||
Cefaclor | 1.42 (1.15, 1.77) | 0.001* | 1.15 (1.06, 1.25) | 0.0006* |
Cefazolin | 1.38 (1.11, 1.72) | 0.004* | 1.15 (1.07, 1 25) | 0.0004* |
Cefeprime | 1.45 (1.16, 1.80 | 0.001* | 1.12 (1.03, 1.21) | 0.006* |
Cefoxitin | 1.41 (1.14, 1.76) | 0.002* | 1.10 (1.01, 1.19) | 0.020* |
Ceftazidime | 1.31 (1.05, 1.62) | 0.02* | 1.07 (0.99, 1.15) | 0.10 |
Caftriaxone | 1.25 (1.01, 1.56) | 0.04* | 1.09 (1.01, 1.18) | 0.03* |
Carbapenams | ||||
Meropenem | 1.28 (0.99, 1.65) | 0.06 | 1.08 (0.99, 1.18) | 0.10 |
Aminoglycosides | ||||
Gentamicin | 1.17 (0.90, 1.51) | 0.23 | 1.01 (0.92, 1.11) | 0.78 |
Fluroroqinolones | ||||
Ciprofloxacin | 1.20 (0.96, 1.51) | 0.11 | 1.03 (0.95, 1.12) | 0.45 |
Levofloxacin | 1.20 (0.95, 1.53) | 0.13 | 1.05 (0.97, 1.14) | 0.25 |
Nilrofurans | ||||
Nitmiurantoin | 1.03 (0.64, 1.65) | 0.9 | 0.90 (0.74, 1.08) | 0.25 |
Tetracyclines | ||||
Tetracyclines | 1.26 (1.02, 1.57) | 0.04* | 1.11 (1.02, 1.20) | 0.010* |
Glycopeptides | ||||
Vancomycin | 2.15 (1.63, 2.84) | <00001 | 1.38 (1.21, 1.56) | <0.0001 |
Significant p-value
The numbers in parentheses are 95% confidence interval bounds. Column 2 represents odds ratios of resistance for polymicrobial versus monomicrobial specimens. Column 4 presents odds ratios of resistance for each additional bacterial species in a specimen.